SCM
XGN icon

Stonepine Capital Management’s Exagen XGN Stock Holding History

Stonepine Capital Management’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-95,747
Closed -$344K – 85
2025
Q1 		$344K Sell
95,747
-155,302
-62% -$586K 0.33% 44
2024
Q4 		$1.03M Sell
251,049
-283,349
-53% -$1.02M 0.83% 30
2024
Q3 		$1.65M Buy
534,398
+175,701
+49% +$455K 1.04% 22
2024
Q2 		$653K Sell
358,697
-25,903
-7% -$43.9K 0.6% 19
2024
Q1 		$612K Sell
384,600
-285,084
-43% -$553K 0.49% 16
2023
Q4 		$1.33M Sell
669,684
-533,807
-44% -$923K 0.58% 15
2023
Q3 		$2.91M Buy
1,203,491
+154,139
+15% +$391K 0.97% 17
2023
Q2 		$3.04M Buy
1,049,352
+12,278
+1% +$34.9K 1.1% 16
2023
Q1 		$2.52M Buy
1,037,074
+183,032
+21% +$473K 0.85% 18
2022
Q4 		$2.05M Sell
854,042
-411,331
-33% -$1.06M 0.86% 15
2022
Q3 		$3.43M Buy
1,265,373
+4,986
+0.4% +$27.8K 1.54% 13
2022
Q2 		$7.24M Buy
1,260,387
+139,347
+12% +$811K 3.37% 14
2022
Q1 		$9M Buy
1,121,040
+262,473
+31% +$2.26M 3.73% 10
2021
Q4 		$9.98M Buy
858,567
+467,930
+120% +$5.48M 4.58% 8
2021
Q3 		$5.31M Buy
390,637
+221,095
+130% +$2.94M 2.42% 11
2021
Q2 		$2.54M Sell
169,542
-21,464
-11% -$329K 1.33% 19
2021
Q1 		$3.34M Buy
+191,006
New +$3.4M 1.81% 17

Other funds holding XGN

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.88% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Stonepine Capital Management's XGN Position: Q2 2025 in Review

Stonepine Capital Management sold out of Exagen (XGN) in Q2 2025, closing a stake of 95,747 shares — an estimated $344K sold.

Stonepine Capital Management first reported a position in XGN in Q1 2021 and held it in 17 quarters. The position peaked at $9.98M in Q4 2021. 53 funds tracked by Wall St. Rank hold XGN as of Q2 2025.

  • Stonepine Capital Management reported no remaining Exagen position as of Q2 2025 after selling out during the quarter.
  • Stonepine Capital Management sold 95,747 Exagen shares in Q2 2025, an estimated $344K.
  • Stonepine Capital Management first reported a position in Exagen in Q1 2021 and held it in 17 quarters.
  • Stonepine Capital Management's Exagen position peaked at $9.98M in Q4 2021.
  • 53 funds tracked by Wall St. Rank held Exagen as of Q2 2025.

Based on Stonepine Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.